File a 30-day mdr.An assessment was conducted.The event is still considered reportable under fda's regulation.It is important to note that during a clinical investigation the customer had difficulty remembering important aspects of the alleged adverse event, including but not limited to whether or not her inhalers were prescribed in the past or if it is a new prescription(s).In addition, the customer did not mention the use of the soclean with her md.The root cause of the customer's experience is unknown.Reporting for due diligence.Soclean believes this complaint is related to the philips recall of the dreamstation 1, not the soclean device.Soclean is processing this complaint in accordance with its complaint handling and quality system processes.
|